Clinical Trial

Minimally Invasive Treatments of the Thyroid

Study acronym: MIPA-MITT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)
Trial Details
NCT Number NCT06333587
Lead Sponsor European Institute of Oncology
Conditions Papillary Thyroid Microcarcinoma
Enrollment 270 participants
Start Date 2022-10-10
Primary Completion 2025-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-27